Barry James exercised Options covering 2,083 BIO-RAD LABORATORIES shares at $0 per share, leaving him with 2,495 shares. Investors can also see a 4,313-derivative-security award and a resulting 2,112 derivative-securities holding, with the award representing 100.0% of that post-award balance.
Key Highlights
- A Sep. 4 award gave Barry James 4,313 derivative securities, representing about 100.0% of his resulting derivative-securities holding.
- James held 2,112 derivative securities after exercising the options.
- The transactions carried SEC codes M, A and F, covering option exercises, an award and reported forfeitures.
BIO-RAD LABORATORIES, INC. (NYSE: BIO) executive Barry James exercised options covering 2,083 shares at $0 per share in transactions dated Sep. 5 and Sep. 6, leaving him with 2,495 shares. James is the company’s EVP and president of LSG, and the reported activity also involved his derivative-securities holdings.
Reported Option Exercises and Holdings
A Sep. 4 award gave James 4,313 derivative securities. His resulting holding after that award was also 4,313 derivative securities, meaning the award represented about 100.0% of the resulting balance. James subsequently exercised options covering 2,083 derivative securities in transactions dated Sep. 5 and Sep. 6 at $0 per share. His derivative-securities holding after those exercises stood at 2,112. The transactions carried code M, which identifies an option exercise. Code A identifies an award, while code F identifies the reported forfeitures. The reported holdings of 2,495 shares and 2,112 derivative securities are separate post-transaction positions. Barry James’s activity therefore covered both common shares and derivative securities of BIO-RAD LABORATORIES, INC.
FAQs
Q: What did Barry James exercise at BIO-RAD LABORATORIES?
A: Barry James exercised options covering 2,083 BIO-RAD LABORATORIES shares at $0 per share. The transactions occurred on Sep. 5 and Sep. 6.
Q: How many BIO-RAD shares did Barry James hold afterward?
A: Barry James held 2,495 BIO-RAD LABORATORIES shares after the reported option exercises on Sep. 5 and Sep. 6. His derivative-securities holding was reported separately at 2,112.
Q: What derivative securities did Barry James receive?
A: Barry James received 4,313 derivative securities on Sep. 4 in a transaction reported with SEC transaction code A. That award represented about 100.0% of his resulting derivative-securities holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.